ARCHIVES

Newest NIH Institute, NIBIB, Gets An Acting Director.

This article is from The Cancer Letter archive.

Vol. 27 No. 19 | May 11, 2001

Download PDF Visit The Full Archive

Related Articles

“Our Job Is to Be The One Agency That Speaks To Cancer”

October 28, 1994

Cancer Advocates Seek 6.5% Increase For NCI In Fiscal 1997

March 8, 1996

AACI, SCO, ACCC Hold Meeting With HCFA On DRG Issue

June 17, 1983

Zaltrap Shows Improvement in Survival In Stage IV Metastatic Colorectal Cancer

July 29, 2011

Bioethics Commission Report Calls For funding To Derive Stem Cells

September 17, 1999

Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends.

August 6, 2004